Since the delivery of our first ultra-widefield device in 2000, optomap⌐ has been the only ultra-widefield retinal imaging technology that captures up to 200° or 82% of the retina in a single image.
California has three versions available to be customizable for use in multiple eyecare settings and the new hardware and software technology will enable practitioners to see more, discover more and eﬀectively treat more ocular pathology thus promoting patient health.
The Medmont E300 offers extreme accuracy for the mapping of a patient’s cornea. It has a standard deviation of error of less than 2 microns. To put that into perspective, the average human hair is 75 microns.
It is also the only Placido Ring Topographer on the market that can map the cornea from Limbus to Limbus. This is a huge advantage when fitting Scleral or GP lenses.
Optovue Ivue OCT
Extensive Clinical Utility
Optovue OCT has a broad range of applications in today’s eye care practices. OCT technology generates high-resolution, cross-sectional and three-dimensional (3D) images of the retina, optic disc and anterior segment, to give you valuable information that aids in the diagnosis and management of a range of ocular diseases.
Diverse Views of the Retina
In addition to cross-sectional images of retinal tissue, Optovue OCT systems include dense 3D cubes of data that can be dissected to visualize individual retinal layers in an en face view, and thickness maps with normative comparison. With this information, you gain new insights into the health of the retina to increase diagnostic confidence and measure your patient’s response to treatment.
QuantifEye has become the industry-standard turnkey program for measuring Macular Pigment Optical Density (MPOD) and supplementation.
Healthy macular pigment is important for three key reasons:
Low macular pigment is a key risk factor for Age-Related Macular Degeneration (AMD)
Protects the photoreceptors from harmful blue light
Enhances visual performance like light sensitivity, glare recovery, contrast sensitivity, and others
Since 2006, QuantifEye has been the industry-standard instrument to measure macular pigment optical density (MPOD). With more than 4-million eyes accurately measured, QuantifEye is scientifically-validated through several clinical studies, and continues to lead the market with the introduction of MPS II – the next generation in macular pigment screening.